To further unravel the molecular mechanisms implicated in the antioxidative effects of BAK against diabetic cardiomyopathy, we have focused on the SIRT1/Nrf2 signaling pathway. The gene discussed is NFE2L2; the disease is diabetic cardiomyopathy.